The global market size of coronary stents is projected to witness significant growth, exceeding $4.8 billion by 2029. Boston Scientific, Medtronic, and Abbott emerged as the key players dominating the majority of the global coronary stents market share. This comprehensive market research encompasses an in-depth analysis of coronary stents companies across over 70 countries worldwide.
The global market size for coronary stents is projected to experience growth throughout the forecast period. The average selling price (ASP) within the coronary stent market is primarily influenced by the dominant drug-eluting stent (DES) segment, which constitutes a significant portion of the total units sold. Over the years, prices of DESs have substantially decreased since their initial introduction in 2003. This decline in prices can be attributed to factors such as unfavorable reimbursement conditions and intense competition within the market. However, moving forward, prices in the coronary stent market are expected to show growth. This increase in prices is driven by the prevailing trend of market consolidation. As the market undergoes consolidation, companies may have more control over pricing strategies, which can contribute to a rise in prices.
Boston Scientific emerged as the leading competitor in the global coronary stent market. The company's success can be largely attributed to its strong position in the drug-eluting stent (DES) market, where it held a significant market share. Boston Scientific offers several product lines, including the PREMIER™ and SYNERGY™ DES, as well as the REBEL™ bare-metal stent (BMS). Notably, the SYNERGY™ DES stands out as the first and only FDA-approved DES with an abluminal bioabsorbable polymer coating available in the U.S. market. The REBEL™ BMS, made of a platinum chromium alloy, is designed to reduce device usage, procedure times, and radiation exposure, providing additional benefits to physicians and patients.
CORONARY STENTS MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Coronary Stents Procedure Volumes
- Market Drivers & Limiters for Each Market Segment
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
CORONARY STENTS PROCEDURE VOLUMES
This study conducted by the publisher on the global coronary stents market includes an analysis of procedure volumes to enhance the accuracy of market sizing. The analysis provides detailed information on procedure volumes spanning a 10-year period and encompassing 70 countries. This comprehensive approach ensures a robust understanding of market dynamics and trends related to coronary stents.CORONARY STENTS MARKET INSIGHTS
The Asia Pacific region emerged as the largest market for coronary stents, demonstrating substantial growth in unit sales. The growth of the coronary stent market in this region is closely linked to the annual volume of percutaneous coronary intervention (PCI) procedures. Any significant changes in the PCI procedure volume directly impact the sales volume of coronary stents. Furthermore, the implementation of systemic healthcare reforms, improved access to healthcare, and rising disposable income in the Asia Pacific region are anticipated to have a positive impact on the market for coronary stents. These factors collectively contribute to the growth and potential of the market in the region.The global market size for coronary stents is projected to experience growth throughout the forecast period. The average selling price (ASP) within the coronary stent market is primarily influenced by the dominant drug-eluting stent (DES) segment, which constitutes a significant portion of the total units sold. Over the years, prices of DESs have substantially decreased since their initial introduction in 2003. This decline in prices can be attributed to factors such as unfavorable reimbursement conditions and intense competition within the market. However, moving forward, prices in the coronary stent market are expected to show growth. This increase in prices is driven by the prevailing trend of market consolidation. As the market undergoes consolidation, companies may have more control over pricing strategies, which can contribute to a rise in prices.
CORONARY STENTS MARKET SHARE INSIGHTS
In 2022, the global coronary stents market was dominated by three key competitors: Boston Scientific, Medtronic, and Abbott.Boston Scientific emerged as the leading competitor in the global coronary stent market. The company's success can be largely attributed to its strong position in the drug-eluting stent (DES) market, where it held a significant market share. Boston Scientific offers several product lines, including the PREMIER™ and SYNERGY™ DES, as well as the REBEL™ bare-metal stent (BMS). Notably, the SYNERGY™ DES stands out as the first and only FDA-approved DES with an abluminal bioabsorbable polymer coating available in the U.S. market. The REBEL™ BMS, made of a platinum chromium alloy, is designed to reduce device usage, procedure times, and radiation exposure, providing additional benefits to physicians and patients.
RESEARCH REGIONAL COVERAGE
- Throughout this comprehensive research series, the author has meticulously covered more than 70 countries worldwide, providing in-depth analysis and insights. Each global region is available as a stand-alone report, allowing you to tailor the data to your specific needs. The regions covered in this series include: North America (the United States and Canada)
- Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
- Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
- Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
- Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
- Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
- Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)
Table of Contents
Coronary Stent Market
List of Charts
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boston Scientific
- Medtronic
- Abbott
- Biosensors
- Biotronik
- Alvimedica
- Balton Medical
- Barty Medical
- Cardionovum
- CeloNova
- Cordis
- Elixir Medical
- Terumo
- WEGO
